Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Preparation of mononuclear cells from synovial tissue.

Beech JT, Brennan FM.

Methods Mol Med. 2007;135:105-19.

PMID:
17951655
2.

Flow cytometric characterization of freshly isolated and culture expanded human synovial cell populations in patients with chronic arthritis.

Van Landuyt KB, Jones EA, McGonagle D, Luyten FP, Lories RJ.

Arthritis Res Ther. 2010;12(1):R15. doi: 10.1186/ar2916. Epub 2010 Jan 27.

3.
4.

Clinical significance of synovial lymphoid neogenesis and its reversal after anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.

Cañete JD, Celis R, Moll C, Izquierdo E, Marsal S, Sanmartí R, Palacín A, Lora D, de la Cruz J, Pablos JL.

Ann Rheum Dis. 2009 May;68(5):751-6. doi: 10.1136/ard.2008.089284. Epub 2008 May 21.

PMID:
18495732
5.

Detection, identification and in vivo treatment responsiveness of bone morphogenetic protein (BMP)-activated cell populations in the synovium of patients with rheumatoid arthritis.

Verschueren PC, Lories RJ, Daans M, Théate I, Durez P, Westhovens R, Luyten FP.

Ann Rheum Dis. 2009 Jan;68(1):117-23. doi: 10.1136/ard.2007.080127. Epub 2008 Feb 14.

PMID:
18276742
6.

Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes.

Zrioual S, Ecochard R, Tournadre A, Lenief V, Cazalis MA, Miossec P.

J Immunol. 2009 Mar 1;182(5):3112-20. doi: 10.4049/jimmunol.0801967.

7.

Resting CD4+ effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell function.

Brennan FM, Smith NM, Owen S, Li C, Amjadi P, Green P, Andersson A, Palfreeman AC, Hillyer P, Foey A, Beech JT, Feldmann M.

Arthritis Res Ther. 2008;10(2):R36. doi: 10.1186/ar2390. Epub 2008 Mar 19.

8.

The pathogenesis of rheumatoid arthritis.

Duke O, Panayi GS.

In Vivo. 1988 Jan-Feb;2(1):95-103. Review.

PMID:
2979825
9.

The role of synovial fibroblasts in mediating joint destruction in rheumatoid arthritis.

Meinecke I, Rutkauskaite E, Gay S, Pap T.

Curr Pharm Des. 2005;11(5):563-8. Review.

PMID:
15720275
10.

LILRA5 is expressed by synovial tissue macrophages in rheumatoid arthritis, selectively induces pro-inflammatory cytokines and IL-10 and is regulated by TNF-alpha, IL-10 and IFN-gamma.

Mitchell A, Rentero C, Endoh Y, Hsu K, Gaus K, Geczy C, McNeil HP, Borges L, Tedla N.

Eur J Immunol. 2008 Dec;38(12):3459-73. doi: 10.1002/eji.200838415.

11.

Characterization of synovial cell clones isolated from rheumatoid arthritis patients: possible involvement of TNF-alpha in reduction of osteoprotegerin in synovium.

Zhao B, Takami M, Miyamoto Y, Suzawa T, Yamada A, Mochizuki A, Yasuhara R, Wang X, Inoue T, Namiki O, Sakamoto K, Kamijo R.

Cytokine. 2008 Jan;41(1):61-70. Epub 2007 Dec 20.

PMID:
18083042
12.

Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunities.

Feldmann M, Brennan F, Bondeson J, Paleolog E, Foxwell B, Maini R.

Transplant Proc. 2001 May;33(3):2085-6. No abstract available.

PMID:
11377461
13.

The role of mesenchymal cells in the pathophysiology of inflammatory arthritis.

Meyer LH, Franssen L, Pap T.

Best Pract Res Clin Rheumatol. 2006 Oct;20(5):969-81. Review.

PMID:
16980218
14.

Synovial lymphoid neogenesis does not define a specific clinical rheumatoid arthritis phenotype.

Thurlings RM, Wijbrandts CA, Mebius RE, Cantaert T, Dinant HJ, van der Pouw-Kraan TC, Verweij CL, Baeten D, Tak PP.

Arthritis Rheum. 2008 Jun;58(6):1582-9. doi: 10.1002/art.23505.

15.

The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synovium.

Wijbrandts CA, Dijkgraaf MG, Kraan MC, Vinkenoog M, Smeets TJ, Dinant H, Vos K, Lems WF, Wolbink GJ, Sijpkens D, Dijkmans BA, Tak PP.

Ann Rheum Dis. 2008 Aug;67(8):1139-44. Epub 2007 Nov 29.

16.

Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.

Bramlage CP, Kaps C, Ungethüm U, Bramlage P, Koziolek M, Wessels J, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR, Häupl T.

Scand J Rheumatol. 2008 Nov-Dec;37(6):401-9. doi: 10.1080/03009740802120010.

PMID:
18830904
17.

Residual inflammation after rituximab treatment is associated with sustained synovial plasma cell infiltration and enhanced B cell repopulation.

Teng YK, Levarht EW, Toes RE, Huizinga TW, van Laar JM.

Ann Rheum Dis. 2009 Jun;68(6):1011-6. doi: 10.1136/ard.2008.092791. Epub 2008 Jul 22.

PMID:
18647852
18.

Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.

Schmidt M, Hartung R, Capellino S, Cutolo M, Pfeifer-Leeg A, Straub RH.

Arthritis Rheum. 2009 Oct;60(10):2913-22. doi: 10.1002/art.24859.

19.

Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.

Kamijo S, Nakajima A, Kamata K, Kurosawa H, Yagita H, Okumura K.

Rheumatology (Oxford). 2008 Apr;47(4):442-50. doi: 10.1093/rheumatology/ken006. Epub 2008 Feb 29.

PMID:
18310134
20.

Expression of IL-19 and its receptors in RA: potential role for synovial hyperplasia formation.

Sakurai N, Kuroiwa T, Ikeuchi H, Hiramatsu N, Maeshima A, Kaneko Y, Hiromura K, Nojima Y.

Rheumatology (Oxford). 2008 Jun;47(6):815-20. doi: 10.1093/rheumatology/ken061. Epub 2008 Apr 8.

PMID:
18397956

Supplemental Content

Support Center